Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
1,3,4-Thiadiazol-2-amine → 5,6-dimethyl-N2-(pyridin-2-ylmethyl)-N4-(1,3,4-thiadiazol-2-yl)pyrimidine-2,4-diamine
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 1,3,4-Thiadiazol-2-amine | HCID 19909 | — |
| 반응물 | N4-cyclopentyl-5,6-dimethyl-N2-(pyridin-2-ylmethyl)pyrimidine-2,4-diamine | HCID 71738410 | — |
| 생성물 | 5,6-dimethyl-N2-(pyridin-2-ylmethyl)-N4-(1,3,4-thiadiazol-2-yl)pyrimidine-2,4-diamine | HCID 71738983 | — |
반응 단계
The titled compound was synthesized according to the procedure described for preparation of N4-cyclopentyl-5,6-dimethyl-N2-(pyridin-2-ylmethyl)pyrimidine-2,4-diamine (Example 29) using 1,3,4-thiadiazol-2-amine instead of cyclopentanamine. The crude material was purified by column chromatography eluting with mixture of chloroform/ethanol/20% water solution of ammonia (200:10:1), and then the final product was washed with diethyl ether to afford the titled compound as a white solid. 1H NMR (300 MHz, DMSO-d6) δ ppm 2.10 (s, 3H), 2.25 (s, 3H), 4.68 (d, J=2.0 Hz, 2H), 7.18-7.51 (m, 3H), 7.70 (t, J=7.8 Hz, 1H), 8.50 (s, 1H), 9.01 (s, 1H), 10.93 (bs, 1H); MS (ESI) m/z 314.1 (M+1)+.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US09447051B2 |
| 출처 데이터셋 | uspto-grants-2016_09 |
| ORD ID | ord-5277dbfa338241d8b46bf49c76b3d205 |
| 출처 메모 | uspto-grants-2016_09 |